LUCAR-DKS1

· Nanjing Legend Biotech Co.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LUCAR-DKS1, covering 2025-12-10 to 2025-12-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LUCAR-DKS1 in Subjects With Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]